“Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture”. Tikrit Journal of Pharmaceutical Sciences, vol. 20, no. 1, June 2026, pp. 20-32, https://doi.org/10.25130/tjphs.2026.20.1.3.20.32.